Sarasin & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,621,724
Closed -$169M 114
2020
Q3
$169M Buy
1,621,724
+278,409
+21% +$28M 2.44% 19
2020
Q2
$123M Buy
1,343,315
+834,189
+164% +$80M 1.97% 22
2020
Q1
$45.9M Buy
509,126
+395,473
+348% +$42.1M 0.9% 35
2019
Q4
$12.9M Hold
113,653
0.2% 61
2019
Q3
$12.3M Buy
113,653
+19,078
+20% +$1.99M 0.2% 62
2019
Q2
$9.21M Buy
94,575
+55,000
+139% +$5.02M 0.16% 72
2019
Q1
$3.6M Hold
39,575
0.07% 92
2018
Q4
$3.6M Sell
39,575
-6,392
-14% -$597K 0.08% 88
2018
Q3
$4.52M Buy
+45,967
New +$4.25M 0.09% 90
2016
Q3
Sell
-14,647
Closed -$1.27M 136
2016
Q2
$1.27M Hold
14,647
0.02% 117
2016
Q1
$1.1M Hold
14,647
0.02% 113
2015
Q4
$1.13M Hold
14,647
0.02% 108
2015
Q3
$980K Sell
14,647
-14,647
-50% -$1.08M 0.02% 112
2015
Q2
$2.17M Sell
29,294
-3,831
-12% -$293K 0.04% 99
2015
Q1
$2.58M Sell
33,125
-51,293
-61% -$3.89M 0.04% 102
2014
Q4
$6.09M Sell
84,418
-7,254
-8% -$504K 0.09% 77
2014
Q3
$5.68M Buy
91,672
+6,694
+8% +$426K 0.08% 78
2014
Q2
$5.42M Sell
84,978
-49,945
-37% -$3.03M 0.08% 81
2014
Q1
$8.3M Buy
+134,923
New +$7.86M 0.12% 63

Other funds holding MDT

Sarasin & Partners's MDT Position: Q4 2020 in Review

Sarasin & Partners sold out of Medtronic (MDT) in Q4 2020, closing a stake of 1,621,724 shares — an estimated $169M sold.

Sarasin & Partners first reported a position in MDT in Q1 2014 and held it in 19 quarters. The position peaked at $169M in Q3 2020. 1,958 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Sarasin & Partners reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Sarasin & Partners sold 1,621,724 Medtronic shares in Q4 2020, an estimated $169M.
  • Sarasin & Partners first reported a position in Medtronic in Q1 2014 and held it in 19 quarters.
  • Sarasin & Partners's Medtronic position peaked at $169M in Q3 2020.
  • 1,958 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Sarasin & Partners's 13F filing for Q4 2020, filed 19 Jan 2021.